Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Graham Ogg

FMedSci


Professor of Dermatology

CD1a; Skin immunology; T cells; innate lymphoid cells

CD1a, T cells and the skin

Skin and mucosae frequently represent the first point of contact with pathogens and allergens, yet we still know relatively little of the role of the surface immune system in clearing such challenges. This is crucially important in understanding the mechanisms of skin diseases and related diseases, and for optimising approaches to cutaneous drug and vaccine delivery. The aim of the group is therefore to understand, at the molecular and cellular level, the role of human cutaneous immune responses in mechanisms of disease, treatment and vaccination.  As well as contributing to an understanding of disease pathogenesis, we aim to translate our findings to changes in clinical practice.

Specifically, we are working on skin T cells which respond to inflammatory lipids that are presented by CD1a.  This turns out to be a very important part skin immune responses and we have been defining the underlying mechanisms. Our findings  are also developing towards new approaches to modulate the CD1a pathway for patient benefit.